Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M83.1Revenue (TTM) $M2.5Net Margin (%)-1,499.3Altman Z-Score-18.9
Enterprise Value $M73.7EPS (TTM) $-2.4Operating Margin %-1,437.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-1,499.3Higher ROA y-yY
Price/Book36.510-y EBITDA Growth Rate %-27.5Quick Ratio4.0Cash flow > EarningsY
Price/Sales22.65-y EBITDA Growth Rate %-6.0Current Ratio4.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-100.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-237.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

SNSS is held by these investors:



SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.870view
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.870view
Parker Geoffrey M.Director 2016-05-26Buy1,583$2.8237.23view
Parker Geoffrey M.Director 2016-05-25Buy8,751$2.8237.23view
Misfeldt DaytonDirector 2015-12-21Buy291,667$5.04-23.21view
Swisher Daniel N JRPresident and CEO 2015-08-25Buy4,167$6.06-36.14view
Ketchum Steven BDirector 2015-07-24Sell1,060$20.76-81.36view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell1,060$20.76-81.36view
Swisher Daniel N JRPresident and CEO 2015-07-24Sell2,119$20.76-81.36view
BAY CITY CAPITAL LLC10% Owner 2015-07-24Sell105,951$20.76-81.36view

Press Releases about SNSS :

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
Sunesis Pharmaceuticals Announces Presentation of The Ohio State University-Sponsored Preclinical St Apr 03 2017 
Sunesis Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference Mar 28 2017 
Sunesis Pharmaceuticals Announces Submission of Responses to the EMA Day 180 List of Outstanding Iss Mar 22 2017 
Roundys Among Largest Insiders' Buys of the Week Dec 31 2015 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 

More From Other Websites
Sunesis Pharmaceuticals Announces Presentation of The Ohio State University-Sponsored Preclinical... Apr 03 2017
Sunesis Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference Mar 28 2017
Sunesis Pharmaceuticals Announces Submission of Responses to the EMA Day 180 List of Outstanding... Mar 22 2017
Sunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
Sunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
Edited Transcript of SNSS earnings conference call or presentation 9-Mar-17 4:00pm GMT Mar 10 2017
Sunesis reports 4Q loss Mar 09 2017
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2016 Financial Results and Recent... Mar 09 2017
Seattle Genetics (SGEN): FDA Lifts Hold on Trial of AML Drug Mar 08 2017
GlaxoSmithKline's Nucala Positive in Label Expansion Study Mar 07 2017
Sunesis to Host Conference Call on March 9th to Discuss Fourth Quarter and Full-Year 2016 Financial... Mar 02 2017
Sunesis Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference Mar 01 2017
Achillion (ACHN) Reports Narrower-Than-Expected Q4 Loss Feb 27 2017
Emergent (EBS) Beats Earnings, Revenue Estimates in Q4 Feb 24 2017
Bayer (BAYRY) Misses on Q4 Earnings; Revenues in Line Feb 23 2017
Pfizer's Leukemia Candidate Gets Priority Review in U.S. Feb 22 2017
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View Feb 17 2017
Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y Feb 16 2017
Prothena (PRTA) Reports Wider-than-Expected Loss in Q4 Feb 15 2017
AMAG Pharma (AMAG) Incurs Loss in Q4, Revenues Lag Estimates Feb 15 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)